These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 24406443)
1. Functional characterization of rare variants in human dopamine receptor D4 gene by genotype-phenotype correlations. Michealraj KA; Jatana N; Jafurulla ; Narayanan L; Chattopadhyay A; Thelma BK Neuroscience; 2014 Mar; 262():176-89. PubMed ID: 24406443 [TBL] [Abstract][Full Text] [Related]
2. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773 [TBL] [Abstract][Full Text] [Related]
3. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist. Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032 [TBL] [Abstract][Full Text] [Related]
4. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine. Czermak C; Lehofer M; Liebmann PM; Traynor J Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344 [TBL] [Abstract][Full Text] [Related]
5. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553 [TBL] [Abstract][Full Text] [Related]
6. SH3 binding domains in the dopamine D4 receptor. Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378 [TBL] [Abstract][Full Text] [Related]
7. Structure and dynamics of DRD4 bound to an agonist and an antagonist using in silico approaches. Jatana N; Thukral L; Latha N Proteins; 2015 May; 83(5):867-80. PubMed ID: 25371112 [TBL] [Abstract][Full Text] [Related]
8. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Asghari V; Sanyal S; Buchwaldt S; Paterson A; Jovanovic V; Van Tol HH J Neurochem; 1995 Sep; 65(3):1157-65. PubMed ID: 7643093 [TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Jovanovic V; Guan HC; Van Tol HH Pharmacogenetics; 1999 Oct; 9(5):561-8. PubMed ID: 10591536 [TBL] [Abstract][Full Text] [Related]
10. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944 [TBL] [Abstract][Full Text] [Related]
11. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells. Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368 [TBL] [Abstract][Full Text] [Related]
13. Action of novel antipsychotics at human dopamine D3 receptors coupled to G protein and ERK1/2 activation. Bruins Slot LA; Palmier C; Tardif S; Cussac D Neuropharmacology; 2007 Aug; 53(2):232-41. PubMed ID: 17588617 [TBL] [Abstract][Full Text] [Related]
14. Multiple dopamine D4 receptor variants in the human population. Van Tol HH; Wu CM; Guan HC; Ohara K; Bunzow JR; Civelli O; Kennedy J; Seeman P; Niznik HB; Jovanovic V Nature; 1992 Jul; 358(6382):149-52. PubMed ID: 1319557 [TBL] [Abstract][Full Text] [Related]
15. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548. Cummings DF; Ericksen SS; Goetz A; Schetz JA J Pharmacol Exp Ther; 2010 Jun; 333(3):682-95. PubMed ID: 20215412 [TBL] [Abstract][Full Text] [Related]
16. Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting. Jatana N; Thukral L; Latha N J Mol Model; 2016 Jan; 22(1):14. PubMed ID: 26680992 [TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC; Maullu C; Onali P Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases. Linz S; Müller J; Hübner H; Gmeiner P; Troschütz R Bioorg Med Chem; 2009 Jul; 17(13):4448-58. PubMed ID: 19481941 [TBL] [Abstract][Full Text] [Related]